| Sanofi-Aventis (Suisse) SA - Zaltrap 200 mg/8 ml, concentré pour solution pour perfusion | | 62676 | | 02 | | Zaltrap 200 mg/8 ml | | concentré pour solution pour perfusion | | L01XX44 | | Aflibercept | | 20.03.2013 | | |
| | Composition | | afliberceptum 200 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, acidum citricum monohydricum, natrii citras dihydricus, natrii chloridum, saccharum, polysorbatum 20, aqua ad iniectabile, q.s. ad solutionem pro 8 ml. | | Packungsbestandteile | | concentré pour solution pour perfusion | | | | | | | | Active Agent | Dose |
|---|
| Afliberceptum | 200mg / 8ml |
| | BAG: Active Agent | Dose |
|---|
| Afliberceptum | 200 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Disodium Phosphate Heptahydrate | | Sodium Chloride | | Natrii Citras Dihydricus | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 20 | | Saccharum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | Durchstechflasche(n) | 777.87 | 862.40 | A | SL | No |
|
|
